Phase III, randomized controlled trial in girls 9-15 years old to evaluate lot consistency of a novel nine-valent human papillomavirus L1 virus-like particle vaccine
- Alain Luxembourg
- , Edson D. Moreira
- , Rudiwilai Samakoses
- , Kyung Hyo Kim
- , Xiao Sun
- , Roger Maansson
- , Erin Moeller
- , Susan Christiano
- , Joshua Chen
Research output: Contribution to journal › Article › peer-review
15
Scopus
citations